Abstract

GI cancer 41. Parra M, Kasler H, McKinsey TA, et al. Protein kinase D1 phosphorylates HDAC7 and 48. Melillo G. Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev induces its nuclear export after T-cell receptor activation. The Journal of biological 2007;26:341e52. chemistry 2005;280:13762e70. 49. Ziello JE, Jovin IS, Huang Y. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway 42. Dequiedt F, Van Lint J, Lecomte E, et al. Phosphorylation of histone deacetylase 7 and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol by protein kinase D mediates T cell receptor-induced Nur77 expression and Med 2007;80:51e60. apoptosis. J Exp Med 2005;201:793e804. 50. Loges S, Mazzone M, Hohensinner P, et al. Silencing or fueling metastasis with 43. von Blume J, Knippschild U, Dequiedt F, et al. Phosphorylation at Ser244 by CK1 VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 2009;15:167e70. determines nuclear localization and substrate targeting of PKD2. EMBO J 51. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant 2007;26:4619e33. progression of tumours to increased local invasion and distant metastasis. Cancer 44. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69 Cell 2009;15:220e31. (Suppl 3):4e10. 52. Bergers G, Hanahan D. Modes of